InvestorsHub Logo
Followers 12
Posts 619
Boards Moderated 0
Alias Born 12/14/2018

Re: hopester post# 2662

Tuesday, 05/12/2020 2:09:10 AM

Tuesday, May 12, 2020 2:09:10 AM

Post# of 3683
Yes. And also remember that Helios is going to finish two trials this year, which will be before any Athx readouts but will definitely boost the stock if positive results are reported.

From their recent earnings call:

And I think one of the other things you said that was so important was that clinical timelines have not been decimated. And I know that Healios had been talking about, hopes this year for both TREASURE and ONE-BRIDGE.



Regarding their MOVID trial or whatever it’s called (for Multistem against covid-induced ARDS), things are moving along quickly. The chaos in the hospitals is not hindering their trial:

we've been inundated with requests from clinical sites that want to participate in our study, because they've seen the power of our data and the impact that we've generated from the exploratory Phase 2 study that we completed, how we showed consistent safety and compelling clinical evidence of benefit, which is supported by the biomarker data that we generated. So there is a lot of interest in terms of sites that want to participate in our trial.



https://www.fool.com/earnings/call-transcripts/2020/05/09/athersys-athx-q1-2020-earnings-call-transcript.aspx